JP2024536403A - 特に心臓プロテーゼの表面を調製する方法 - Google Patents

特に心臓プロテーゼの表面を調製する方法 Download PDF

Info

Publication number
JP2024536403A
JP2024536403A JP2024520991A JP2024520991A JP2024536403A JP 2024536403 A JP2024536403 A JP 2024536403A JP 2024520991 A JP2024520991 A JP 2024520991A JP 2024520991 A JP2024520991 A JP 2024520991A JP 2024536403 A JP2024536403 A JP 2024536403A
Authority
JP
Japan
Prior art keywords
acid
phenolic
biological
fluid
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024520991A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536403A5 (https=
Inventor
ナーゾ，フィリッポ
ガンダリア，アレッサンドロ
ステファネッリ，ウーゴ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocompatibility Innovation Srl
Original Assignee
Biocompatibility Innovation Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT102021000025796A external-priority patent/IT202100025796A1/it
Application filed by Biocompatibility Innovation Srl filed Critical Biocompatibility Innovation Srl
Publication of JP2024536403A publication Critical patent/JP2024536403A/ja
Publication of JP2024536403A5 publication Critical patent/JP2024536403A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
JP2024520991A 2021-10-06 2022-10-06 特に心臓プロテーゼの表面を調製する方法 Pending JP2024536403A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163252728P 2021-10-06 2021-10-06
EP21201230 2021-10-06
US63/252,728 2021-10-06
EP21201230.6 2021-10-06
IT102021000025796 2021-10-08
IT102021000025796A IT202100025796A1 (it) 2021-10-08 2021-10-08 Metodo per la preparazione di superfici, in particolare di protesi cardiache
PCT/IB2022/059550 WO2023057947A1 (en) 2021-10-06 2022-10-06 A method for the preparation of surfaces, particularly of cardiac prosthesis

Publications (2)

Publication Number Publication Date
JP2024536403A true JP2024536403A (ja) 2024-10-04
JP2024536403A5 JP2024536403A5 (https=) 2026-04-13

Family

ID=83558312

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024520991A Pending JP2024536403A (ja) 2021-10-06 2022-10-06 特に心臓プロテーゼの表面を調製する方法

Country Status (6)

Country Link
EP (1) EP4412670A1 (https=)
JP (1) JP2024536403A (https=)
AU (1) AU2022360405A1 (https=)
CA (1) CA3230427A1 (https=)
IL (1) IL311780A (https=)
WO (1) WO2023057947A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025257595A1 (en) 2024-06-12 2025-12-18 Biocompatibility Innovation S.r.l. Preserving solution

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6350251B1 (en) * 2000-01-18 2002-02-26 Biolink Corporation Biocidal locks
WO2007133479A2 (en) * 2006-05-10 2007-11-22 Cook Incorporated Delivery of elastin-stabilizing compound within a body lumen
US8357387B2 (en) * 2007-12-21 2013-01-22 Edwards Lifesciences Corporation Capping bioprosthetic tissue to reduce calcification
ES2568730T3 (es) * 2010-10-06 2016-05-04 The Board Of Trustees Of The University Of Arkansas Composiciones anti-biopelícula y métodos de uso
WO2020201055A1 (en) * 2019-03-29 2020-10-08 Evonik Operations Gmbh Preparations containing berry extracts for use in the prophylaxis and/or treatment of viral infections caused by pneumoviridae
CN113646015B (zh) * 2019-04-10 2023-01-10 美利奴生命科学有限公司 防止生物假体中使用的组织降解和退化的方法
US11951078B2 (en) * 2019-05-22 2024-04-09 Biocompatibility Innovation S.r.l. Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices

Also Published As

Publication number Publication date
IL311780A (en) 2024-05-01
AU2022360405A1 (en) 2024-03-14
CA3230427A1 (en) 2023-04-13
WO2023057947A1 (en) 2023-04-13
EP4412670A1 (en) 2024-08-14

Similar Documents

Publication Publication Date Title
Fidalgo et al. A sterilization method for decellularized xenogeneic cardiovascular scaffolds
US11951078B2 (en) Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices
US7550152B2 (en) Tissue graft scaffold made from cholecyst-derived extracellular matrix
US4994237A (en) Microwave preservation of bioprostheses
US20060193885A1 (en) Implantable biomaterial and a method of producing same
Liu et al. Curcumin-crosslinked acellular bovine pericardium for the application of calcification inhibition heart valves
JP2025111450A (ja) 石灰化沈着物の形成を防止し、生物学的マトリックス中の異種抗原を不活化するための方法
Zhang et al. Tunicate-mimetic antibacterial hydrogel based on metal ion crosslinking and chitosan functionalization for wound healing
AU2003205255B2 (en) Calcification-resistant fixation
JP2024536403A (ja) 特に心臓プロテーゼの表面を調製する方法
US12419994B2 (en) Process for prevention of degradation and degeneration of tissue used in bioprosthesis
Lan et al. A combination of hydrogen bonding and chemical covalent crosslinking to fabricate a novel swim-bladder-derived dry heart valve material yields advantageous mechanical and biological properties
US20240342330A1 (en) Method for the preparation of surfaces, particularly of cardiac prosthesis
Deepak et al. Investigation of hemocompatibility and physicochemical properties of acellular caprine pericardium for biomedical applications
CN118055784A (zh) 一种用于制备表面、特别是心脏假体表面的方法
Singh et al. Activity of MMP‐9 after repair of abdominal wall defects with acellular and crosslinked bovine pericardium in rabbit
IT202100025796A1 (it) Metodo per la preparazione di superfici, in particolare di protesi cardiache
US20020137024A1 (en) Methods for preparation of bioprosthetic tissue and implantable devices comprising such bioprosthetic tissue
Rallapalli et al. Hemocompatibility and surface properties of bovine pericardial patches: Effects of gamma sterilization
Moore et al. Nonaldehyde sterilization of biologic tissue for use in implantable medical devices
WO2022077271A1 (en) Polymeric flavonoids and use thereof
Guhathakurta et al. Thrombogenicity studies of three different variants of processed bovine pericardium
US20020122816A1 (en) Use of 3-hydroxypropinoaldehyde in crosslinking and sterilizing a biomolecule, and a biocompatible implant, substitute or wound dressing containing the crosslinked biomolecule
RU2846289C1 (ru) Способ производства коллаген-ламининового матрикса для заживления язв, ожогов, ран и дефектов кожи человека
Shenoy et al. Differential Surface Thrombogenicity of Heparin Coated Bovine Pericardium: Implication in Bioprosthetic Valve Fabrication

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251006

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251006

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260402